SCHEMBL2347724

SCHEMBL2347724

CCCCCCCCCCCCCCC(Oc1ccccc1C)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
NR1I2 O75469 1/20 0.46
LMNA P02545 1/20 0.46
CHRM2 P08172 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADRA2A P08913 1/20 0.46
MAPT P10636 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
CTRC Q99895 1/20 0.41
PPARG P37231 3/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14565994 0.87 CTRC (0.50) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL8408945 0.85 MAPT (0.45) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL8406995 0.82 SMN1; SMN2 (0.42) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL14159647 0.80 CTRC (0.53) CTRCPPARGPTGESALOX5PPARA
SCHEMBL9353141 0.79 HSD17B10 (0.42) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL30639267 0.78 CTRC (0.54) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL14484236 0.78 L3MBTL1 (0.39) MEN1KMT2ATDP1PPARGPTGES
SCHEMBL10743959 0.76 PPARG (0.42) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL11521450 0.76 KMT2A (0.53) MEN1NR1I2LMNACHRM2CYP3A4
SCHEMBL22680777 0.75 ALOX15 (0.40) MEN1NR1I2LMNACHRM2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173748-B1 INDOLYL PYRROLIDINES FOR THE TREATMENT OF CANCER ARQULE INC (US) 2011-08-31 EP disclosed